Back
Krystal Biotech Vs. Catalyst Pharmaceuticals Industry Stock Comparison
Sell
38
KRYS
Krystal Biotech
Last Price:
169.28
Seasonality Move:
18.42%
Sell
49
CPRX
Catalyst Pharmaceuticals
Last Price:
16.15
Seasonality Move:
16.35%
Sell
38
Krystal Biotech (KRYS)
is a Sell
Is Krystal Biotech a Buy, Sell or Hold?
- The current Krystal Biotech [KRYS] share price is $169.25. The Score for KRYS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- KRYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $16.14. The Score for CPRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KRYS Stock Price Chart
What is Krystal Biotech's stock price today?
-
The Krystal Biotech share price today is $169.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRYS is experiencing slight selling pressure.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $16.14
The current trend is moderately bullish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.
KRYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.48 | Buy |
| Relative Strength Index (14 RSI): | 59.97 | Buy |
| Chaikin Money Flow: | -129151 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 53.94 | Buy |
| Chaikin Money Flow: | -659450 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.83 - 16.25) | Buy |
| Bollinger Bands (100): | (14.25 - 16.27) | Buy |
KRYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 163.24 | Buy |
| 20-day SMA: | 160.03 | Buy |
| 50-day SMA: | 167.15 | Buy |
| 200-day SMA: | 131.81 | Buy |
| 8-day EMA: | 164.3 | Buy |
| 20-day EMA: | 162.67 | Buy |
| 50-day EMA: | 160.5 | Buy |
| 200-day EMA: | 136.49 | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.48 | Sell |
| 20-day SMA: | 15.65 | Buy |
| 50-day SMA: | 15.7 | Buy |
| 200-day SMA: | 14.41 | Buy |
| 8-day EMA: | 16.31 | Sell |
| 20-day EMA: | 15.93 | Buy |
| 50-day EMA: | 15.61 | Buy |
| 200-day EMA: | 14.78 | Buy |
Krystal Biotech Earnings Growth & KRYS Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.66 per share, an increase next quarter of $0.28 per share, an increase this year of $3.59 per share, and an increase next year of $2.08 per share.
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.14 per share, and an increase next year of $0.20 per share.
Krystal Biotech Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Catalyst Pharmaceuticals Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||